Mitochondrial-Derived Peptides in Research Literature: Humanin and MOTS-c
Humanin and MOTS-c are two peptides encoded within mitochondrial DNA, identified through independent lines of molecular biology research beginning in the early 2000s. This guide summarizes their chemical identity and the research fields in which each is documented in the literature.
What Is a Mitochondrial-Derived Peptide?
Mitochondrial DNA is best known for encoding components of the cellular respiratory chain, but research since the early 2000s has identified additional short open reading frames within mitochondrial DNA capable of producing peptides.
Compounds translated from these regions are referred to in the literature as mitochondrial-derived peptides, or MDPs.
This is a comparatively recent and still-developing area of molecular biology, distinct in origin and identity from the synthetic and hypothalamic-signaling peptide families more commonly discussed in research-peptide catalogs.
Humanin: Discovery and Identity
Humanin was identified in 2001 by independent research groups screening cDNA libraries, who traced it to a short open reading frame within the mitochondrial 16S ribosomal RNA gene region.
It is documented in the literature as a 24-residue peptide, with its sequence and identity data catalogued in standard peptide and genomic databases.
MOTS-c: Discovery and Identity
MOTS-c, short for mitochondrial open reading frame of the 12S rRNA type-c, was identified in mid-2010s research as a 16-residue peptide encoded within the mitochondrial 12S ribosomal RNA region.
This is a separate mitochondrial-DNA locus from the one associated with Humanin. Its identity is likewise documented by sequence in standard reference databases.
How These Compounds Are Studied in the Literature
Both Humanin and MOTS-c are referenced in mitochondrial-biology and cellular-metabolism research literature, where the focus has generally been on their role and behavior within specific cell and animal model systems.
As with any compound discussed on this site, describing a research field is not the same as describing an effect. Findings reported in this literature are preclinical, are not established in humans, and this guide does not restate them as claims.
Why This Family Is Distinct from Metabolic/Incretin Research Peptides
Because mitochondrial-derived peptides are sometimes discussed alongside cellular-metabolism research, it is worth being explicit: this family is structurally, mechanistically, and regulatorily distinct from GLP-1-class investigational research compounds.
Those compounds carry active FDA enforcement attention and are the subject of a separate part of this site's compliance content.
Nothing in this guide should be read as adjacent to, or a substitute for, that GLP-1-specific enforcement literacy content. The same exclusions applied there — no comparison framing and no metabolic-outcome language — apply here as well.
Frequently Asked Questions
What is a mitochondrial-derived peptide?
It is a peptide translated from a short open reading frame located within mitochondrial DNA, distinct from the DNA regions that encode the classic respiratory-chain proteins. Humanin and MOTS-c are two documented examples.
When was Humanin first identified?
Humanin was identified in 2001 by research groups independently screening cDNA libraries, who traced its origin to the mitochondrial 16S rRNA gene region.
What does "MOTS-c" stand for?
MOTS-c stands for mitochondrial open reading frame of the 12S rRNA type-c, reflecting the specific mitochondrial-DNA locus from which it is translated.
Are mitochondrial-derived peptides regulated the same way as GLP-1-class investigational compounds?
This guide does not make a regulatory-status claim about any individual compound. Regulatory status is compound-specific and should be confirmed through primary FDA sources. Researchers should not assume equivalence between compound families based on a shared research field.
References
Draft citations — verify before publication. Confirm author, title, journal, year, volume, page range, and DOI against the primary source before publication or regulatory review.
- Hashimoto Y, et al. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Aβ. Proceedings of the National Academy of Sciences USA. 2001;98(11):6336–6341.
- Lee C, et al. MOTS-c identity and characterization literature. Verify the exact citation, including article title, journal, publication year, volume, pages, and DOI, against the primary source before publication.
- General reference on mitochondrial DNA open reading frames and mitochondrial-derived-peptide nomenclature. Verify the primary reference before publication.